We are live on ! Find out more
SBC icon

SBC Medical Group

42 hedge funds and large institutions have $5.69M invested in SBC Medical Group in 2025 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 21 increasing their positions, 10 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

536% more capital inflows, than outflows

Capital inflows: $2.09M | Capital outflows: $329K

110% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 10

0.46% more ownership

Funds ownership: 0.82% → 1.29% (+0.46%)

0% more funds holding

Funds holding: 42 → 42 (0)

0% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 7

Holders
42
Holders Change
–
Holders Change %
0%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
21
Reduced
10
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

SBC Hedge Fund Activity: Q4 2025 in Review

42 of the 8,302 institutional investors tracked by Wall St. Rank reported a position in SBC Medical Group (SBC) for Q4 2025, worth a combined $5.69M — up 54% from $3.68M a quarter earlier.

Fund positioning in SBC was balanced in Q4 2025: 7 funds opened new positions, 7 closed out, 21 added to existing stakes and 10 trimmed.

The largest buyer was Vanguard Group, adding an estimated $719K. The largest seller was Millennium Management, exiting entirely with an estimated $219K sold.

  • 42 institutional investors held SBC Medical Group (SBC) as of Q4 2025, unchanged from Q3 2025.
  • Funds reported $5.69M of SBC Medical Group stock for Q4 2025, up 54% quarter-over-quarter.
  • 7 funds opened new SBC Medical Group positions in Q4 2025 and 7 closed out, a net change of 0 holders.
  • The largest SBC Medical Group buyer in Q4 2025 was Vanguard Group, an estimated $719K added.
  • The largest SBC Medical Group seller in Q4 2025 was Millennium Management, an estimated $219K sold.

Based on aggregated 13F filings for Q4 2025.